TelsartAm-HCT is a triple combination of Telmisartan, Amlodipine and Hydrochlorothiazide. Telmisatan belongs to the class of Angiotensin-2 Receptor Blockers (ARB), Amlodipine is a Calcium Channel Blocker (CCB) while Hydrochlorothiazide is a diuretic. TelsartAm-HCT is indicated for the management of hypertension. The use of this fixed-dose triple combination in the management of hypertension can facilitate the attainment of BP goals and improve cardiovascular outcomes at lower doses of the component medications compared with monotherapy.